On The Horizon
On the Horizon will be a spinoff of WTR's Small-Cap Spotlight focusing exclusively on our Horizons client as well as other micro- and nano-cap companies.
On The Horizon
Latest Episodes
Perion Networks (PERI): Algo Trading for Ads — Perion's AI Layer for a Trillion-Dollar Market
In this episode of the On The Horizon podcast, Tal Jacobson, CEO of Perion Network (NASDAQ: PERI), joins host Tim Gerdeman and WTR's James Kisner to discuss how the repositioned, AI-native Perion is tackling fragmentation in the trillion-dollar...
Algorhythm Holdings (RIME): SemiCab’s AI Platform Tackles Empty Miles in Global Freight
On this episode of On the Horizon, Gary Atkinson, CEO of Algorhythm Holdings (NASDAQ: RIME), joins host Tim Gerdeman and WTR’s James Kisner. The discussion centers on SemiCab, the company’s AI-driven collaborative optimization platform...
Enlivex (ENLV): CEO Details Why the Company Is Pioneering a Dual Biotech and Digital Asset Strategy
In this episode of I, Oren Hershkovitz, CEO of Enlivex, joins host Tim Gerdeman, Vice Chair, Co-Founder, and CMO of Water Tower Research, along with Dr. John Roy, WTR’s Senior Equity Research Analyst. The conversation explores the e...
ExoZymes (EXOZ): Unlocking Hard-to-Scale Molecules with AI-Driven, Cell-Free Biomanufacturing
ExoZymes (NASDAQ: EXOZ) CEO Michael Heltzen joins Tim Gerdeman and Robert Sassoon in this episode of the On The Horizon podcast to discuss the company’s AI-driven, cell-free biomanufacturing platform and how it aims to overcome longstanding sca...
Decoy Therapeutics (DCOY): CEO Rick Pierce on the Company’s Groundbreaking Approach to Drug Development in the AI/ML Era
In this episode of the WTR Healthcare Happenings podcast, Rick Pierce, CEO of Decoy Therapeutics (NASDAQ: DCOY), joins Tim Gerdeman, Vice Chair, Co‑Founder, and CMO of Water Tower Research, and Robert Sassoon, WTR’s Healthcare Research Analyst....